Design and methods of the Population Assessment of Tobacco and Health (PATH) Study
- PMID: 27507901
- PMCID: PMC5299069
- DOI: 10.1136/tobaccocontrol-2016-052934
Design and methods of the Population Assessment of Tobacco and Health (PATH) Study
Abstract
Background: This paper describes the methods and conceptual framework for Wave 1 of the Population Assessment of Tobacco and Health (PATH) Study data collection. The National Institutes of Health, through the National Institute on Drug Abuse, is partnering with the Food and Drug Administration's (FDA) Center for Tobacco Products to conduct the PATH Study under a contract with Westat.
Methods: The PATH Study is a nationally representative, longitudinal cohort study of 45 971 adults and youth in the USA, aged 12 years and older. Wave 1 was conducted from 12 September 2013 to 15 December 2014 using Audio Computer-Assisted Self-Interviewing to collect information on tobacco-use patterns, risk perceptions and attitudes towards current and newly emerging tobacco products, tobacco initiation, cessation, relapse behaviours and health outcomes. The PATH Study's design allows for the longitudinal assessment of patterns of use of a spectrum of tobacco products, including initiation, cessation, relapse and transitions between products, as well as factors associated with use patterns. Additionally, the PATH Study collects biospecimens from consenting adults aged 18 years and older and measures biomarkers of exposure and potential harm related to tobacco use.
Conclusions: The cumulative, population-based data generated over time by the PATH Study will contribute to the evidence base to inform FDA's regulatory mission under the Family Smoking Prevention and Tobacco Control Act and efforts to reduce the Nation's burden of tobacco-related death and disease.
Keywords: Prevention; Public policy; Surveillance and monitoring.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Conflict of interest statement
Figures
Similar articles
-
Overview of tobacco use transitions for population health.Tob Control. 2020 May;29(Suppl 3):s134-s138. doi: 10.1136/tobaccocontrol-2019-055367. Tob Control. 2020. PMID: 32321846 Free PMC article.
-
Harmonizing Cigar Survey Data Across Tobacco Centers of Regulatory Science, Center for Tobacco Products, and Population Assessment of Tobacco and Health Studies: The Cigar Collaborative Research Group.Nicotine Tob Res. 2021 Jan 7;23(1):212-218. doi: 10.1093/ntr/ntz201. Nicotine Tob Res. 2021. PMID: 31665435 Free PMC article.
-
CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.MMWR Suppl. 2014 Oct 31;63(4):3-27. MMWR Suppl. 2014. PMID: 25356673
-
Tobacco control in the United States--recent progress and opportunities.CA Cancer J Clin. 2009 Nov-Dec;59(6):352-65. doi: 10.3322/caac.20037. CA Cancer J Clin. 2009. PMID: 19897839 Review.
-
Monitoring the tobacco use epidemic I. Overview: Optimizing measurement to facilitate change.Prev Med. 2009 Jan;48(1 Suppl):S4-10. doi: 10.1016/j.ypmed.2008.08.007. Epub 2008 Sep 9. Prev Med. 2009. PMID: 18809429 Review.
Cited by
-
Associations between vaping and self-reported respiratory symptoms in young people in Canada, England and the US.BMC Med. 2024 May 29;22(1):213. doi: 10.1186/s12916-024-03428-6. BMC Med. 2024. PMID: 38807205 Free PMC article.
-
Use of Electronic Nicotine Delivery Systems and Age of Asthma Onset Among US Adults and Youths.JAMA Netw Open. 2024 May 1;7(5):e2410740. doi: 10.1001/jamanetworkopen.2024.10740. JAMA Netw Open. 2024. PMID: 38758558 Free PMC article.
-
Development and initial validation of a new self-report measure to assess perceived dependence on tobacco and nicotine products.Sci Rep. 2024 May 2;14(1):10098. doi: 10.1038/s41598-024-60790-4. Sci Rep. 2024. PMID: 38698227 Free PMC article.
-
Respiratory symptoms and outcomes among cigar smokers: findings from the Population Assessment of Tobacco and Health (PATH) study waves 2-5 (2014-2019).Respir Res. 2024 Apr 27;25(1):185. doi: 10.1186/s12931-024-02818-x. Respir Res. 2024. PMID: 38678212 Free PMC article.
-
Association between tobacco product use and respiratory health and asthma-related interference with activities among U.S. Adolescents.Prev Med Rep. 2024 Apr 1;41:102712. doi: 10.1016/j.pmedr.2024.102712. eCollection 2024 May. Prev Med Rep. 2024. PMID: 38586468 Free PMC article.
References
-
- US Department of Health EaW. Smoking and health: report of the Advisory Committee to the Surgeon General of the Public Health Service. Washington DC: US Department of Health, Education, and Welfare, Public Health Service; 1964. (Report No.: PHS Publication No. 1103).
-
- US Department of Health and Human Services. The health consequences of smoking—50 years of progress: a report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
-
- Rostron BL, Chang CM, Pechacek TF. Estimation of cigarette smoking-attributable morbidity in the United States. JAMA Intern Med. 2014;174:1922–8. - PubMed
-
- Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014. (Report No.: NSDUH Series H-48, HHS Publication No. (SMA) 14-4863).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical